The DOI matches its Crossref record.
Overproduction of p53 antigen makes established cells highly tumorigenic
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TP53 was initially thought to be an oncogene, and high levels of p53 conferred significant tumorigenic potential to rat embryonic fibroblasts.16,17”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 22
- Klein, G. (ed.) Advances in Viral Oncology Vol. 2 (Raven, New York, (1982).
- Crawford, L. V. Int. Rev. exp. Path. 25, 1–50 (1983).
- Eliyahu, D., Raz, A., Gruss, P., Givol, D. & Oren, M. Nature 312, 646–649 (1984). · DOI · Paper page
- Parada, L. F., Land, H., Weinberg, R. A., Wolf, D. & Rotter, V. Nature 312, 649–651 (1984). · DOI · Paper page
- Jenkins, J. R., Rudge, K. & Currie, G. A. Nature 312, 651–654 (1984). · DOI · Paper page
- Steinberg, B., Pollack, R., Topp, W. & Botchan, M. Cell 13, 19–32 (1978). · doi:10.1016/0092-8674(78)90134-4
- Mulligan, R. C. & Berg, P. Proc. natn. Acad. Sci. U.S.A. 78, 2072–2076 (1981). · DOI · Paper page
- Oren, M., Maltzman, W. & Levine, A. J. Molec. Cell Biol. 1, 101–110 (1981). · DOI · Paper page
- Mora, P. T., Chandrasekaran, K., Hoffmann, J. C. & McFarland, V. W. Molec. Cell Biol. 2, 763–771 (1982). · doi:10.1128/mcb.2.7.763
- Keath, E. J., Caimi, P. G. & Cole, M. D. Cell 39, 339–348 (1984). · DOI · Paper page
- Bienz, B., Zakut-Houri, R., Givol, D. & Oren, M. EMBO J. 3, 2179–2183 (1984). · DOI · Paper page
- Pinhasi, O. & Oren, M. Molec. Cell Biol 4, 2180–2186 (1984). · doi:10.1128/mcb.4.10.2180
- Ellis, R. W. et al. J. Virol. 36, 408–420 (1980). · DOI · Paper page
- Laimins, L. A., Gruss, P., Pozzatti, R. & Khoury, G. J Virol 49, 183–189 (1984). · DOI · Paper page
- Rotter, V., Friedman, H., Katz, A., Zerivitz, K. & Wolf, D. J Immun. 131, 329–333 (1983). · doi:10.4049/jimmunol.131.1.329
- Harlow, E., Crawford, L. V., Pirn, D. C. & Williamson, N. M. J Virol. 39, 861–869 (1981). · DOI · Paper page
- Galos, R. A., Williams, J., Binger, M. H. & Flint, S. J. Cell 17, 945–956 (1979). · DOI
- Maniatis, T., Fritsch, E. F. & Sambrook, J. Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Laboratory, New York, (1982).
- Lehrach, H., Diamond, D., Wozney, J. M. & Boedtker, H. Biochemistry 16, 4743–4751 (1977). · DOI · Paper page
- Thomas, P. S. Proc. natn. Acad. Sci. U.S.A. 77, 5201–5205 (1980). · DOI · Paper page
- Zakut-Houri, R. et al. Nature 306, 594–597 (1983). · DOI · Paper page
- Oren, M., Bienz, D., Givol, D., Rechavi, G. & Zakut, R. EMBO J. 2, 1633–1639 (1983). · DOI
Cited by
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
The p53 proto-oncogene can act as a suppressor of transformation
Finlay, C. A., Hinds, P. W., & Levine, A. J. (1989) · Cell · doi:10.1016/0092-8674(89)90045-7 · Cited by 1,987
The first 30 years of p53: growing ever more complex.
Levine, A. J., & Oren, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2723 · Cited by 1,967
Self-citationFinlay, C. A., Hinds, P. W., Tan, T. H., Eliyahu, D., Oren, M., & Levine, A. J. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.531 · Cited by 1,144
Self-citationTargeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
Gain of function mutations in p53
Dittmer, D., Pati, S., Zambetti, G., Chu, S., Teresky, A. K., Moore, M., Finlay, C., & Levine, A. J. (1993) · Nature Genetics · doi:10.1038/ng0593-42 · Cited by 894
p53: oncogene or anti-oncogene?
Lane, D. P., & Benchimol, S. (1990) · Genes & Development · doi:10.1101/gad.4.1.1 · Cited by 795
Michalovitz, D., Halevy, O., & Oren, M. (1990) · Cell · doi:10.1016/0092-8674(90)90113-s · Cited by 769
Self-citationTumor suppressor p53: Biology, signaling pathways, and therapeutic targeting
Hernández Borrero, L. J., & El-Deiry, W. S. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2021.188556 · Cited by 748
Wild-type p53 can inhibit oncogene-mediated focus formation.
Eliyahu, D., Michalovitz, D., Eliyahu, S., Pinhasi-Kimhi, O., & Oren, M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.22.8763 · Cited by 692
Self-citationThe Action of Oncogenes in the Cytoplasm and Nucleus
Weinberg, R. A. (1985) · Science · doi:10.1126/science.2997917 · Cited by 689
Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types
Willis, T. G., Jadayel, D. M., Du, M.-Q., Peng, H., Perry, A. R., Abdul-Rauf, M., Price, H., Karran, L., Majekodunmi, O., Wlodarska, I., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80957-5 · Cited by 658
P53 expression in breast cancer
Cattoretti, G., Rilke, F., Andreola, S., D'Amato, L., & Delia, D. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910410204 · Cited by 601
Hinds, P., Finlay, C., & Levine, A. J. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.739-746.1989 · Cited by 577
Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein.
Martinez, J., Georgoff, I., Martinez, J., & Levine, A. J. (1991) · Genes & Development · doi:10.1101/gad.5.2.151 · Cited by 527
BANKS, L., MATLASHEWSKI, G., & CRAWFORD, L. (1986) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1986.tb09919.x · Cited by 495
p53 Research: The Past Thirty Years and the Next Thirty Years
Lane, D., & Levine, A. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000893 · Cited by 454
Lavigueur, A., Maltby, V, Mock, D., Rossant, J., Pawson, T., & Bernstein, A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.9.3982 · Cited by 394
Zhu, D., Caveney, S., Kidder, G. M., & Naus, C. C. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.5.1883 · Cited by 362
Shaulian, E., Zauberman, A., Ginsberg, D., & Oren, M. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5581 · Cited by 342
Self-citationSpecific interaction between the p53 cellular tumour antigen and major heat shock proteins
Pinhasi-Kimhi, O., Michalovitz, D., Ben-Zeev, A., & Oren, M. (1986) · Nature · doi:10.1038/320182a0 · Cited by 329
Self-citationCharacterization of the human p53 gene.
Lamb, P., & Crawford, L. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1379 · Cited by 327
MDM2 is a Central Node in the p53 Pathway: 12 Years and Counting
Bond, G., Hu, W., & Levine, A. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009053332627 · Cited by 308
Harris, C. C. (1996) · Carcinogenesis · doi:10.1093/carcin/17.6.1187 · Cited by 285
A variation in the structure of the protein-coding region of the human p53 gene
Buchman, V. L., Chumakov, P. M., Ninkina, N. N., Samarina, O. P., & Georgiev, G. P. (1988) · Gene · doi:10.1016/0378-1119(88)90196-5 · Cited by 278
Monoclonal antibody analysis of p53 expression in normal and transformed cells
Yewdell, J. W., Gannon, J. V., & Lane, D. P. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.444-452.1986 · Cited by 264
Metadata
- Authors
- Eliyahu, D., Michalovitz, D., & Oren, M.
- Venue
- Nature
- Published
- 1985-07
- Volume
- 316
- Issue
- 6024
- Pages
- 158-160
- ISSN
- 0028-0836
- 1476-4687
- Cited by
- 146
- References
- 0
- Language
- en
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.